BNP Paribas Knock-Out DVA/ DE000PC6W1Z1 /
2024-05-17 4:51:48 PM | Chg.-0.12 | Bid5:56:54 PM | Ask5:56:54 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.28EUR | -8.57% | 1.17 Bid Size: 23,400 |
1.20 Ask Size: 23,400 |
DaVita Inc | 150.3189 USD | 2078-12-31 | Put |
GlobeNewswire
04-26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
2023-11-17
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
2023-08-15
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
2022-03-21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
2022-03-07
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2022-02-10
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
2021-10-07
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
2021-10-01
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
2021-09-09
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire
2021-09-09
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development